Amgen, Up 42% This Year, Is Broadly Outperforming Its Peers. Here’s What Its Earnings Say.

Amgen beat Wall Street’s top- and bottom-line expectations late Tuesday, but there were puts and takes across the board.

The post Amgen, Up 42% This Year, Is Broadly Outperforming Its Peers. Here’s What Its Earnings Say. appeared first on Investor’s Business Daily.